Specifically, asprosin was positively correlated with WBC in the total study population but was not correlated with other inflammation makers (e.g., CRP, TNF-α, IL-6, or IL-8), in the T2DM or PCOS group or their subgroups, while the results for inflammation markers (TNF-α, IL-6, or IL-8) in healthy control and T2DM subjects have been reported many times in literature [32–37]. This evidence concerns the gene CRP and type 2 diabetes mellitus.